Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
NCT03987152
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Vascular Malformations
Interventions
DRUG:
Sirolimus
Sponsor
Radboud University Medical Center